Compounders Research Compare

NEXGEL, Inc.(NXGL)

Medical - Instruments & Supplies · Langhorne, PA

$0.17-0.00 (-0.71%)

Delayed quote: Oct 6, 2026, 2:27 PM EDT

About NEXGEL, Inc.

NEXGEL, Inc. is a company that develops and produces advanced hydrogels and gels. These materials are characterized by their significant water content, aqueous polymer composition, and electron beam cross-linking technology. NEXGEL's diverse product range serves crucial applications across several sectors, including wound care management, medical diagnostic tools, transdermal drug delivery systems, and cosmetic formulations. The company was founded in 1997 and operated under the name AquaMed Technologies, Inc. until it rebranded as NEXGEL, Inc. in November 2019. Its headquarters are located in Langhorne, Pennsylvania.

Langhorne, PA

19 employees

Healthcare / Medical - Instruments & Supplies

Sector: Healthcare
Industry: Medical - Instruments & Supplies
CEO: Brian J. Kieser

View full financials

Price/FCF Ratio: N/A

Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The Price/FCF ratio is N/A as of 2026-10-06T18:32:25.456Z.

Stored calculation inputs

Calculation as of: 2026-10-06T18:32:25.456Z.

Quote observation: 2026-10-06T18:27:59.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 1,430,697
TTM free cash flow · period ending 2026-06-30: -3,326,000

FMP input reference: c1171bf84d9e01e227179f4391907e0b7edeaef3f5f58c6a2b8957218a297583

P/E Ratio|FCF Growth|Operating Margin|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

NXGL Price/FCF Ratio Metrics

PRICE/FCF RATIO

N/A

NXGL Competitors' Price/FCF Ratio

NEXGEL, Inc.

Current

Market Cap

$1.43M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

INVO Fertility, Inc.

Market Cap

$1.43M

Price/FCF Ratio

N/A

TTM Avg

8.14

3Y Avg

8.14

5Y Avg

8.14

Curis, Inc.

Market Cap

$1.43M

Price/FCF Ratio

N/A

TTM Avg

58.11

3Y Avg

58.11

5Y Avg

58.11

Jupiter Neurosciences, Inc.

Market Cap

$1.39M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PMGC Holdings Inc.

Market Cap

$1.48M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Lakewood-Amedex Biotherapeutics, Inc.

Market Cap

$1.49M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Artelo Biosciences, Inc.

Market Cap

$1.36M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Genprex, Inc.

Market Cap

$1.35M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NewcelX Ltd.

Market Cap

$1.34M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Silo Pharma, Inc.

Market Cap

$1.60M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PRICE/FCF RATIO	TTM	3Y	5Y
NEXGEL, Inc. (NXGL)	$1.43M	N/A	N/A	N/A	N/A
INVO Fertility, Inc. (IVF)vs ›	$1.43M	N/A	8.14	8.14	8.14
Curis, Inc. (CRIS)vs ›	$1.43M	N/A	58.11	58.11	58.11
Jupiter Neurosciences, Inc. (JUNS)vs ›	$1.39M	N/A	N/A	N/A	N/A
PMGC Holdings Inc. (ELAB)vs ›	$1.48M	N/A	N/A	N/A	N/A
Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs ›	$1.49M	N/A	N/A	N/A	N/A
Artelo Biosciences, Inc. (ARTL)vs ›	$1.36M	N/A	N/A	N/A	N/A
Genprex, Inc. (GNPX)vs ›	$1.35M	N/A	N/A	N/A	N/A
NewcelX Ltd. (NCEL)vs ›	$1.34M	N/A	N/A	N/A	N/A
Silo Pharma, Inc. (SILO)vs ›	$1.60M	N/A	N/A	N/A	N/A

Free Cash Flow Valuation

P/FCF Ratio

N/A

FCF Yield

N/A

Price/FCF Ratio Formula & Definition

P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

P/E Ratio FCF Growth Operating Margin All Metrics